The report compiles 26 sourced data points on market growth, FDA approvals, and the purity problem dividing regulated ...

While the manufacturer is on the list of authorized GLP-1 importers, FDA inspectors found the company relabeled APIs from another site in a potential attempt to “circumvent safeguards.” A Chinese ...

The New York Times reported on March 31, 2026 that the U.S. Food and Drug Administration is moving to lift its ban on more than a dozen injectable peptides that were restricted in 2023 over ...

The association between inflammation, infection, and venous thrombosis has long been recognized; yet, only in the last decades have we begun to understand the mechanisms through which the immune and ...

Testing identified significant impurity formation when tirzepatide is compounded with B12 variants, suggesting chemical incompatibility that is not evaluated under FDA review pathways. Uncertainty ...

Compounded versions of tirzepatide (Mounjaro, Zepbound) containing vitamin B12 pose a potential safety risk to the public, Eli Lilly warned in an open letter on Thursday. Following laboratory testing, ...